Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

689 disclosures on record

Evolution of the disclosed total

0%1%2%3%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
Date	Fund	% of capital
July 17, 2018	AHL Partners LLP	0.49%
July 16, 2018	WorldQuant, LLC	0.59%
July 10, 2018	Oxford Asset Management	0.49%
July 4, 2018	Oxford Asset Management	0.50%
July 2, 2018	WorldQuant, LLC	0.61%
June 18, 2018	WorldQuant, LLC	0.59%
June 15, 2018	AQR Capital Management, LLC	2.49%
June 13, 2018	AQR Capital Management, LLC	2.50%
June 12, 2018	AQR Capital Management, LLC	2.49%
June 8, 2018	AQR Capital Management, LLC	2.50%
June 7, 2018	AQR Capital Management, LLC	2.49%
June 5, 2018	AHL Partners LLP	0.59%
June 1, 2018	WorldQuant, LLC	0.69%
May 31, 2018	Millennium International Management LP	0.46%
May 30, 2018	WorldQuant, LLC	0.72%
May 29, 2018	AHL Partners LLP	0.68%
May 25, 2018	Oxford Asset Management	0.49%
May 24, 2018	Oxford Asset Management	0.50%
May 23, 2018	Oxford Asset Management	0.49%
May 22, 2018	Millennium International Management LP	0.57%
May 21, 2018	Millennium International Management LP	0.61%
May 17, 2018	AHL Partners LLP	0.70%
May 10, 2018	Millennium International Management LP	0.59%
May 9, 2018	Millennium International Management LP	0.60%
May 7, 2018	WorldQuant, LLC	0.60%
May 4, 2018	WorldQuant, LLC	0.59%
May 3, 2018	Millennium International Management LP	0.59%
May 2, 2018	AHL Partners LLP	0.61%
April 30, 2018	AQR Capital Management, LLC	2.59%
April 30, 2018	Millennium International Management LP	0.60%
April 27, 2018	WorldQuant, LLC	0.66%
April 25, 2018	WorldQuant, LLC	0.70%
April 23, 2018	AHL Partners LLP	0.50%
April 20, 2018	Millennium International Management LP	0.57%
April 17, 2018	WorldQuant, LLC	0.61%
April 11, 2018	AQR Capital Management, LLC	2.61%
April 11, 2018	WorldQuant, LLC	0.59%
April 6, 2018	WorldQuant, LLC	0.66%
April 3, 2018	Oxford Asset Management	0.50%
March 29, 2018	AQR Capital Management, LLC	2.51%
March 23, 2018	WorldQuant, LLC	0.80%
March 20, 2018	AQR Capital Management, LLC	2.42%
March 19, 2018	Millennium International Management LP	0.69%
March 16, 2018	Millennium International Management LP	0.70%
March 14, 2018	WorldQuant, LLC	0.71%
March 14, 2018	Millennium International Management LP	0.69%
March 13, 2018	AQR Capital Management, LLC	2.30%
March 8, 2018	AQR Capital Management, LLC	2.29%
March 7, 2018	AQR Capital Management, LLC	2.19%
March 7, 2018	WorldQuant, LLC	0.62%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Akzo Nobel N.V. 9.86% of the capital sold short
Pharming Group N.V. 7.95% of the capital sold short
Signify N.V. 7.52% of the capital sold short
Imcd N.V. 4.65% of the capital sold short
Fugro N.V. 4.20% of the capital sold short
DSM-Firmenich AG 3.48% of the capital sold short
Basic-Fit N.V. 3.43% of the capital sold short
PostNL N.V. 2.55% of the capital sold short
NSI N.V. 2.01% of the capital sold short
Alfen N.V. 1.85% of the capital sold short
Arcadis N.V. 1.72% of the capital sold short
Sligro Food Group N.V. 1.55% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=10